EDGAR Filing Documents for 0001349929-16-000107

Form 8-K - Current report:

SEC Accession No. 0001349929-16-000107

Filing Date

2016-09-09

Accepted

2016-09-09 07:36:07

Documents

Period of Report

2016-09-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kxseptember2016offering.htm	8-K	47463
2	EXHIBIT 4.1	exhibit41formofwarrant.htm	EX-4.1	116424
3	EXHIBIT 5.1	exhibit51lowensteinopinion.htm	EX-5.1	8180
4	EXHIBIT 10.1	exhibit101cgixspa.htm	EX-10.1	262025
5	EXHIBIT 10.2	exhibit102engageletter.htm	EX-10.2	56389
6	EXHIBIT 99.1	exhibit991pressreleasesept.htm	EX-99.1	13839
7		cgixengagementletterimage1.jpg	GRAPHIC	73249
8		exhibit991pressreleas_image1.gif	GRAPHIC	2671
	Complete submission text file	0001349929-16-000107.txt		610457

Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070

Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200

CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)